Safety outcomes associated with the moderna COVID-19 vaccine (mRNA-1273): a literature review
Open Access
- 5 May 2023
- journal article
- review article
- Published by Taylor & Francis Ltd in Expert Review of Vaccines
- Vol. 22 (1), 393-409
- https://doi.org/10.1080/14760584.2023.2209177
Abstract
Current safety data from Phase 3 clinical trials have concluded that apart from transient local and systemic reactions, no safety concerns were identified for the Moderna COVID-19 vaccine (mRNA-1273). However, Phase 3 studies are insufficient to detect rare adverse events (AEs). A literature search of the two major electronic databases, Embase and PubMed, was performed to enable the identification and characterization of all relevant articles from December 2020 to November 2022. This narrative review summarizes the key safety outcomes associated with the mRNA-1273 vaccine to inform healthcare decisions and increase public awareness of mRNA-1273 vaccine safety. The primary adverse events (AEs) reported within a diverse population, receiving the mRNA-1273 vaccine, were; localized injection site pain, fatigue, headache, myalgia, and chills. In addition, the mRNA-1273 vaccine was also associated with; less than a 1-day change in the menstrual cycle, a 10-fold higher risk of myocarditis and pericarditis within young males aged 18–29 years and increased levels of anti-polyethylene glycol (PEG) antibodies. The transient nature of commonly observed AEs and the rare occurrence of severe events within mRNA-1273 recipients show no significant safety concerns which should prevent vaccination. However, large-scale epidemiological studies with longer follow-up periods are required to surveillance rare safety outcomes.Keywords
This publication has 33 references indexed in Scilit:
- Venous thromboembolism in cancer patients: a population-based cohort studyBlood, 2021
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineThe New England Journal of Medicine, 2021
- Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older AdultsThe New England Journal of Medicine, 2020
- Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticalsAdvanced Drug Delivery Reviews, 2020
- An overview of COVID-19Journal of Zhejiang University-SCIENCE B, 2020
- Advanced paternal age is associated with an increased risk of spontaneous miscarriage: a systematic review and meta-analysisHuman Reproduction Update, 2020
- Effects of Ageing on the Immune System: Infants to ElderlyScandinavian Journal of Immunology, 2016
- Gender differences in myocarditis: a nationwide study in FinlandEuropean Heart Journal, 2013
- Randomized Controlled TrialsDeutsches Ärzteblatt international, 2011
- REVIEW ARTICLE: The Immune System in Pregnancy: A Unique ComplexityAmerican Journal of Reproductive Immunology, 2010